Entity Details
Primary name |
C1QC_HUMAN |
Entity type |
UniProt |
Source |
Source Link |
Details
Accession | P02747 |
EntryName | C1QC_HUMAN |
FullName | Complement C1q subcomponent subunit C |
TaxID | 9606 |
Evidence | evidence at protein level |
Length | 245 |
SequenceStatus | complete |
DateCreated | 1986-07-21 |
DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
Subcellular Location |
Secreted |
Domains
Show/Hide Table
Domain | Name | Category | Type |
IPR001073 | C1q domain | Domain | Domain |
IPR008160 | Collagen triple helix repeat | Repeat | Repeat |
IPR008983 | Tumour necrosis factor-like domain superfamily | Family | Homologous superfamily |
Diseases
Show/Hide Table
Disease ID | Source | Name | Description |
613652 | OMIM | Complement component C1q deficiency (C1QD) | A disorder caused by impaired activation of the complement classical pathway. It generally leads to severe immune complex disease with features of systemic lupus erythematosus and glomerulonephritis. The disease is caused by variants affecting the gene represented in this entry. |
Drugs
Show/Hide Table
Drug | Name | Source | Type |
DB00002 | Cetuximab | Drugbank | biotech |
DB00005 | Etanercept | Drugbank | biotech |
DB00110 | Palivizumab | Drugbank | biotech |
DB00111 | Daclizumab | Drugbank | biotech |
DB00112 | Bevacizumab | Drugbank | biotech |
DB01593 | Zinc | Drugbank | small molecule |
DB09130 | Copper | Drugbank | small molecule |
DB14487 | Zinc acetate | Drugbank | small molecule |
DB14533 | Zinc chloride | Drugbank | small molecule |
DB14548 | Zinc sulfate, unspecified form | Drugbank | small molecule |
Interactions
8 interactions